Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
RVMDW | US
-0.29
-15.34%
Healthcare
Biotechnology
30/06/2024
20/03/2026
1.60
1.80
1.80
1.53
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
109.7%1 month
97.1%3 months
264.1%6 months
226.6%-
-
-
0.05
0.05
-
-
-
-569.47M
-
-
-
-77.52K
-
-
-40.73
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.55
Range1M
0.66
Range3M
2.89
Rel. volume
0.78
Price X volume
24.11K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| XOMAP | XOMAP | Biotechnology | 25.6 | 0 | -0.58% | 26.27 | 121.93% |
| XOMA Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock | XOMAO | Biotechnology | 25.33 | 0 | -0.04% | 25.57 | 121.93% |
| Rocket Pharmaceuticals Inc. Warrant | RCKTW | Biotechnology | 0.0158 | 0 | -21.00% | n/a | 0.00% |
| ICUCW | ICUCW | Biotechnology | 0.0261 | 0 | n/a | -45.50% | |
| Humacyte Inc | HUMAW | Biotechnology | 0.0887 | 0 | -7.31% | n/a | -63.37% |
| EyeGate Pharmaceuticals Inc | EYEG | Biotechnology | 34.9646 | 0 | -0.98% | n/a | |
| COEPW | COEPW | Biotechnology | 0.0121 | 0 | 22.22% | n/a | 25.11% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
No data | |||||||
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | - | - |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 264.13 | - | Riskier |
| Debt to Equity | 0.05 | -1.23 | Expensive |
| Debt to Assets | 0.05 | 0.25 | Cheaper |
| Market Cap | - | - | - |